| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LLY | Common Stock | Award | $9,518,027 | +12,910 | +12% | $737.26 | 123,738 | 12 Feb 2024 | Direct | |
| holding | LLY | Common Stock | 70,000 | 12 Feb 2024 | By Trust | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | LLY | Restricted Stock Unit | Award | $0 | +8,989 | $0.000000 | 8,989 | 12 Feb 2024 | Common Stock | 8,989 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. |
| F2 | Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. |